newsfilter
← Latest News
Business Wire·

WaterMill Asset Management Addresses Ziopharm Oncology’s Latest Distortion and Recent Threat

NEW YORK--(BUSINESS WIRE)--WaterMill Asset Management Corp. (together with its affiliates, “WaterMill” or “we”) today responded to the latest element of the low-road campaign that Ziopharm Oncology, Inc. (NASDAQ: ZIOP) (“Ziopharm” or the “Company”) is waging in response to our consent solicitation.